TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15472496

Group type: EXPERIMENTAL
Intervention: Calcium antagonist
Number of subjects: 1086

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme
Number of subjects: 1086

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker
Number of subjects: 1086

Group type: EXPERIMENTAL
Intervention: More-intensive BP-lowering group
Number of subjects: 1086

Group type: EXPERIMENTAL
Intervention: Less-intensive BP-lowering group
Number of subjects: 1086
Study: 11379373

Group type: EXPERIMENTAL
Intervention: Dietary beverage containing isoflavones
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoflavone-free, isocaloric placebo preparation
Number of subjects: 24
Study: 9281212

Group type: EXPERIMENTAL
Intervention: Screening with faecal occult-blood tests (Hemoccult-II) every two years for 10 years
Number of subjects: 60933

Group type: COMPARATOR
Intervention: Control group (unscreened)
Number of subjects: 60933
Study: 8299854

Group type: EXPERIMENTAL
Intervention: Ketanserin 40 mg twice daily for 12 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg once daily for 12 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ketanserin plus Enalapril (both at original dosage) for 12 weeks
Number of subjects: 25
Study: 3526267

Group type: EXPERIMENTAL
Intervention: Early physical therapy
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional follow‐up care
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Both groups (infants weighing less than 750 g at birth)
Number of subjects: 134
Study: 31987962

Group type: EXPERIMENTAL
Intervention: SABR with DIL boost (35 Gy to prostate, 25 Gy to pelvis, 50 Gy to DIL in 5 fractions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: SABR without DIL boost (40 Gy to prostate, 25 Gy to pelvis in 5 fractions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SABR with DIL boost
Number of subjects: 60

Group type: COMPARATOR
Intervention: SABR without DIL boost
Number of subjects: 60
Study: 28834191

Group type: EXPERIMENTAL
Intervention: Combined treatment with fractional CO2 laser and PRP
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combined treatment with fractional CO2 laser and NB-UVB
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fractional CO2 laser alone
Number of subjects: 80

Group type: COMPARATOR
Intervention: PRP alone
Number of subjects: 80
Study: 27716149

Group type: EXPERIMENTAL
Intervention: AST-120 (9 g/day)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 583
Study: 24179987

Group type: EXPERIMENTAL
Intervention: Sonic oscillating diamond burs
Number of subjects: 56

Group type: COMPARATOR
Intervention: High-speed rotating diamond burs
Number of subjects: 56
Study: 22094492

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO(4))
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 87
Study: 20482537

Group type: EXPERIMENTAL
Intervention: Uterine artery Doppler test combined with aspirin treatment
Number of subjects: 0
Study: 18684084

Group type: EXPERIMENTAL
Intervention: PTH
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: ALN
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: PTH-ALN
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: CMB-ALN
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: ALN-ALN
Number of subjects: 238

Group type: COMPARATOR
Intervention: PTH-PLB
Number of subjects: 238
Study: 16026136

Group type: EXPERIMENTAL
Intervention: Probiotic strain Enterococcus faecium M-74 (2x10^9 CFU) plus 50 microg of selenium, administered daily for 56 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 43
Study: 12488294

Group type: EXPERIMENTAL
Intervention: Letrozole 1.0 mg once daily
Number of subjects: 157

Group type: COMPARATOR
Intervention: Fadrozole 1.0 mg twice daily
Number of subjects: 157
Study: 14635294

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Range of motion/muscle strengthening (ROM/MS) exercise
Number of subjects: 10
Study: 9093891

Group type: EXPERIMENTAL
Intervention: Polysulphone low-flux dialyzers (F6HPS) rinsed with 1000 ml of saline plus 2000 IU of heparin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Polysulphone high-flux dialyzers (F6OS) rinsed with 1000 ml of saline plus 2000 IU of heparin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both groups rinsed with 500 ml of saline without heparin
Number of subjects: 16
Study: 8475360

Group type: EXPERIMENTAL
Intervention: Amiodarone treatment
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 190
Study: 2946981

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31722605

Group type: EXPERIMENTAL
Intervention: Mastectomy
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Lumpectomy
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Lumpectomy plus radiotherapy
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Lumpectomy plus radiotherapy and hormone therapy
Number of subjects: 803
Study: 29655670

Group type: EXPERIMENTAL
Intervention: 15-second handrub application
Number of subjects: 20

Group type: COMPARATOR
Intervention: 30-second handrub application
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Trained volunteers
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untrained volunteers
Number of subjects: 20
Study: 27278130

Group type: EXPERIMENTAL
Intervention: QuinteT Recruitment Intervention (QRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integration of QRI into feasibility/pilot or main phase of RCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of QRI to ongoing RCTs experiencing recruitment shortfalls
Number of subjects: 0
Study: 24790019

Group type: EXPERIMENTAL
Intervention: Eccentric training (n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Reference group (n = 14)
Number of subjects: 29
Study: 22553930

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 136
Study: 20977015

Group type: EXPERIMENTAL
Intervention: Mindfulness training program
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study: 18753076

Group type: EXPERIMENTAL
Intervention: Continuous propofol infusion via the common carotid artery (IC group, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous propofol infusion via the median cubital vein (IV group, n=20)
Number of subjects: 40
Study: 15358623

Group type: EXPERIMENTAL
Intervention: VKORC1 1173CC genotype
Number of subjects: 147

Group type: COMPARATOR
Intervention: VKORC1 CT genotype
Number of subjects: 147

Group type: COMPARATOR
Intervention: VKORC1 TT genotype
Number of subjects: 147
Study: 12602461

Group type: EXPERIMENTAL
Intervention: 10 mg bisoprolol
Number of subjects: 19
Study: 9651125

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 0
Study: 7702019

Group type: EXPERIMENTAL
Intervention: Lactating women
Number of subjects: 37

Group type: COMPARATOR
Intervention: Nonlactating women and never pregnant women using oral contraceptives
Number of subjects: 37
Study: 3402100

Group type: EXPERIMENTAL
Intervention: Radical trimming of the inferior turbinates
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Anterior trimming of the inferior turbinates
Number of subjects: 18
Study: 31628698

Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/day
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Cariprazine 3.0 mg/day
Number of subjects: 493

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 493
Study: 30622590

Group type: EXPERIMENTAL
Intervention: Hou Gu Mi Xi (HGMX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28285121

Group type: EXPERIMENTAL
Intervention: Tailored, progressive, multidomain physical rehabilitation intervention
Number of subjects: 27
Study: 25801579

Group type: EXPERIMENTAL
Intervention: Outpatient uterine polypectomy under local anaesthetic
Number of subjects: 507

Group type: COMPARATOR
Intervention: Inpatient uterine polypectomy under general anaesthesia
Number of subjects: 507
Study: 23852067

Group type: EXPERIMENTAL
Intervention: Fiber-reinforced resin bonded bridge
Number of subjects: 23

Group type: COMPARATOR
Intervention: Removable partial denture
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 22001875

Group type: EXPERIMENTAL
Intervention: Adjuvanted 2.5 μg RRV vaccine
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: All vaccine formulations and doses
Number of subjects: 382
Study: 19497765

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sevoflurane (group S)
Number of subjects: 36
Study: 17121639

Group type: EXPERIMENTAL
Intervention: Light resistance training (15-week intervention period, average training time of 5 min/working day, 25 min/week)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No training and no guidance (15-week control period)
Number of subjects: 90
Study: 15624747

Group type: EXPERIMENTAL
Intervention: Tazarotene cream
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Adapalene and tretinoin microsponge gels
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Tazarotene cream and adapalene creams
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Adapalene gel
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Lower retinoid concentrations
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Vehicle (gel vs cream)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Normal skin
Number of subjects: 253
Study: 11380642

Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Almotriptan (various doses 2-150 mg)
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Almotriptan
Number of subjects: 2500
Study: 9399190

Group type: EXPERIMENTAL
Intervention: Consistency‐gradated diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (ate as they wished)
Number of subjects: 14
Study: 7956991

Group type: EXPERIMENTAL
Intervention: Fine flour meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coarse flour meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cracked grain meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Whole grain meal
Number of subjects: 10
Study: 3902590

Group type: EXPERIMENTAL
Intervention: Prednisolone 0.5 mg/kg/day plus a normal diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Elemental diet plus oral framycetin, colistin and nystatin
Number of subjects: 16
Study: 30086036

Group type: EXPERIMENTAL
Intervention: Plate Fixation (PF)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Nonoperative Treatment (NOT)
Number of subjects: 160
Study: 27656477

Group type: EXPERIMENTAL
Intervention: Intranasal Fluticasone propionate aqueous nasal spray
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral Montelukast
Number of subjects: 120
Study: 24901723

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 108
Study: 22496084

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 20549654

Group type: EXPERIMENTAL
Intervention: Pycnogenol
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 19192656

Group type: EXPERIMENTAL
Intervention: Liposomal cisplatin (lipoplatin)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional cisplatin
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Liposomal cisplatin with 5-fluorouracil (5-FU)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional cisplatin with 5-fluorouracil (5-FU)
Number of subjects: 46
Study: 17499304

Group type: EXPERIMENTAL
Intervention: Auricular acupressure (relaxation group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham treatment (sham treated group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 15496623

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 545

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 545
Study: 10871977

Group type: EXPERIMENTAL
Intervention: Intervention group (physician, nurse, and social worker collaboration)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control group (care as usual)
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 543
Study: 9105140

Group type: EXPERIMENTAL
Intervention: Complete immediate dentures
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Complete immediate overdentures on lower canines with Dyna Direct magnetic attachments
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Complete immediate overdentures on lower canines without Dyna Direct magnetic attachments
Number of subjects: 74
Study: 1389734

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Power exercise training
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no formal exercise training)
Number of subjects: 55
Study: 4040019

Group type: EXPERIMENTAL
Intervention: Endoscopic evacuation of intracerebral hematomas using a suction-irrigation system and ultrasonic morcellement device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study: 31838780

Group type: EXPERIMENTAL
Intervention: Music intervention group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Emollient group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 31323184

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (830-nm, 30-mW laser)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 27416912

Group type: EXPERIMENTAL
Intervention: Carfilzomib (10-min intravenous infusion; 20 mg/m2 on days 1 and 2 of cycle 1; 27 mg/m2 thereafter)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Low-dose corticosteroids (84 mg of dexamethasone or equivalent) with optional cyclophosphamide (1400 mg) for 28-day cycles
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Carfilzomib
Number of subjects: 315

Group type: COMPARATOR
Intervention: Control (low-dose corticosteroids with optional cyclophosphamide)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Control
Number of subjects: 315
Study: 26464841

Group type: EXPERIMENTAL
Intervention: Group psychoeducational programme (8 continuous 90-minute sessions, 3 times a week)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study: 23229881

Group type: EXPERIMENTAL
Intervention: Intermittent exercise with active recovery (IEA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intermittent exercise with passive recovery (IEP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study: 21868187

Group type: EXPERIMENTAL
Intervention: Dietary counselling to halve fat intake (Group 1)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Healthy eating advice only (Group 2)
Number of subjects: 107
Study: 19241060

Group type: COMPARATOR
Intervention: Acute caffeine abstinence (placebo after 14 days of caffeine)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chronic caffeine administration (400 mg daily for > or =14 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Acute caffeine administration
Number of subjects: 16
Study: 16838826

Group type: EXPERIMENTAL
Intervention: Taper-off program with group therapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Taper-off program without group therapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lower daily benzodiazepine dosage at the start of tapering off
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Substantial dosage reduction by patients themselves just before tapering off
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Less severe benzodiazepine dependence (measured by Lack of Compliance subscale)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: No use of alcohol
Number of subjects: 180
Study: 12782534

Group type: EXPERIMENTAL
Intervention: Magnesium-aluminum-hydroxide-simethicone suspension (MgAl)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 10
Study: 10697140

Group type: EXPERIMENTAL
Intervention: 7 days of bismuth-based triple therapy (amoxicillin, metronidazole, bismuth subcitrate)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 14 days of bismuth-based triple therapy (amoxicillin, metronidazole, bismuth subcitrate)
Number of subjects: 90
Study: 9351030

Group type: EXPERIMENTAL
Intervention: Omeprazole 60 mg twice daily plus Amoxicillin 750 mg three times daily for 10 days
Number of subjects: 95

Group type: COMPARATOR
Intervention: Ranitidine prophylaxis 150 mg at night for 2 years
Number of subjects: 95
Study: 8224263

Group type: EXPERIMENTAL
Intervention: Clonidine (0.300 mg administered orally) once
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Growth hormone-releasing factor (GH-RF) (1 micrograms/kg IV) repeated twice
Number of subjects: 13

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Growth hormone-releasing factor
Number of subjects: 13
Study: 3910523

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ranitidine plus Caved-S
Number of subjects: 100
Study: 31604477

Group type: EXPERIMENTAL
Intervention: Salt Swap intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control information leaflet
Number of subjects: 40
Study: 29860740

Group type: EXPERIMENTAL
Intervention: Delayed PCI (n=30)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Stented group (n=21)
Number of subjects: 96
Study: 26992483

Group type: EXPERIMENTAL
Intervention: Video segment of peers consuming bell pepper (vegetable condition)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nonfood video segment or no video (control condition)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Vegetable DVD condition
Number of subjects: 42
Study: 25355977

Group type: EXPERIMENTAL
Intervention: e-mail
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fax
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: no-message control group
Number of subjects: 0
Study: 22207322

Group type: EXPERIMENTAL
Intervention: Iron infusion during HD session
Number of subjects: 10

Group type: COMPARATOR
Intervention: Iron preparations (iron gluconate, iron sucrose, iron dextran, ferric carboxymaltose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Culture of mononuclear cells with iron preparations
Number of subjects: 10

Group type: COMPARATOR
Intervention: Generic formulation of iron sucrose
Number of subjects: 10
Study: 20598032

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg/6 h)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 microg/6 h)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol
Number of subjects: 220

Group type: COMPARATOR
Intervention: Vaginal misoprostol
Number of subjects: 220
Study: 18076346

Group type: EXPERIMENTAL
Intervention: sapropterin 10 mg/kg/day (n = 41)
Number of subjects: 485

Group type: COMPARATOR
Intervention: placebo (n = 47)
Number of subjects: 485
Study: 16195288

Group type: EXPERIMENTAL
Intervention: Sulfadoxine‐pyrimethamine
Number of subjects: 2485

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2485
Study: 11772188

Group type: EXPERIMENTAL
Intervention: Enhanced-intervention group (home-safety visit by a community health worker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-intervention group (safety counseling and referral to the children's safety center)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children's safety center visitors
Number of subjects: 0
Study: 9688015

Group type: EXPERIMENTAL
Intervention: High-dose albuterol (two 5.0 mg doses administered during 40 minutes)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard-dose albuterol (three 2.5 mg doses every 20 minutes)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: High-dose albuterol
Number of subjects: 160
Study: 7867110

Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thiopentone/Propofol mixture
Number of subjects: 60
Study: 2530123

Group type: EXPERIMENTAL
Intervention: High-dosage multivitamin and mineral supplements
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 236108

Group type: EXPERIMENTAL
Intervention: Triazolam, 0.4 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Triazolam, 0.8 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Flurazepam, 15 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Flurazepam, 30 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: All active medications
Number of subjects: 25
Study: 31981135

Group type: EXPERIMENTAL
Intervention: Community health campaign
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Counselor-administered home-based testing
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Distribution of HIV self-test kits at local pharmacies
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Two community-based testing services provided concurrently
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Access to antiretroviral therapy (ART)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Multi-disease testing availability
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: US$0.85 incentive
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Perceived risk of having HIV
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Age group comparison
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Income comparison
Number of subjects: 203
Study: 31314954

Group type: EXPERIMENTAL
Intervention: AZ12048189
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25